|
Post by harryx1 on Feb 3, 2016 14:15:48 GMT -5
|
|
|
Post by od on Feb 3, 2016 14:19:14 GMT -5
D - I understand what cjc was saying. I am suggesting that if the rep was simply a jerk, having nothing to do with SNY, it does not prove the point. Perhaps the rep was reflecting SNY's disregard for Afrezza, but having spend most of my career in the industry, I don't believe the sales force has insights into the intentions of the C-suite. Clearly you do not understand what I was saying. Dictatorsaureus described it perfectly, and then you went back in your own direction. You're the only one who suggested that ground level local reps where acting on "C-suite" orders. I believe my experience with this rep is just one example of what has happen across the country. INSTEAD of SNY's sales reps influencing and changing the old school ideas of docs & endos, by supporting and educating on Afrezza, they themselves were influenced by the push back against Afrezza and got on board with it. Almost as if they were embarrassed by their little sister, and now, they're saving face with the rest of the industry by jumping on board with the "yea I knew it wouldn't work either" attitude. That attitude from the SNY reps is what scared me the moment I heard SNY was splitting. If we couldn't gain traction with an ally like SNY, then how the heck are we going to get anywhere when they're against us too? Not to mention, they're supposedly "with us" until the agreement is over which is an absolute JOKE. All these reps are out saving face and probably have more negative comments on Afrezza than our competition does. OH YEA, let's add that our money will run out close to the time we can even get Afrezza back in MNKD's hands. Sry folks,,, not feeling too optimistic today. You all can use beer, wine & liquor to ease the pain but none of them work for me any more. A tall picture of Kool-aid is the only thing that helps me sleep. A near term buy out of something is the only way I can see us surviving, and I hope that is what all the recent moves have been setting up for. You are correct, I did not pick-up on your point from the original post. I now get it, and agree with you.
|
|
|
Post by factspls88 on Feb 3, 2016 14:20:10 GMT -5
Sanofi marketing of Afrezza is a joke and in my opinion harmful given the crappy creative that they are utilizing.
|
|
|
Post by joeypotsandpans on Feb 3, 2016 14:26:21 GMT -5
Clearly you do not understand what I was saying. Dictatorsaureus described it perfectly, and then you went back in your own direction. You're the only one who suggested that ground level local reps where acting on "C-suite" orders. I believe my experience with this rep is just one example of what has happen across the country. INSTEAD of SNY's sales reps influencing and changing the old school ideas of docs & endos, by supporting and educating on Afrezza, they themselves were influenced by the push back against Afrezza and got on board with it. Almost as if they were embarrassed by their little sister, and now, they're saving face with the rest of the industry by jumping on board with the "yea I knew it wouldn't work either" attitude. That attitude from the SNY reps is what scared me the moment I heard SNY was splitting. If we couldn't gain traction with an ally like SNY, then how the heck are we going to get anywhere when they're against us too? Not to mention, they're supposedly "with us" until the agreement is over which is an absolute JOKE. All these reps are out saving face and probably have more negative comments on Afrezza than our competition does. OH YEA, let's add that our money will run out close to the time we can even get Afrezza back in MNKD's hands. Sry folks,,, not feeling too optimistic today. You all can use beer, wine & liquor to ease the pain but none of them work for me any more. A tall picture of Kool-aid is the only thing that helps me sleep. A near term buy out of something is the only way I can see us surviving, and I hope that is what all the recent moves have been setting up for. You are correct, I did not pick-up on your point from the original post. I now get it, and agree with you. Just an fyi, the rep I know felt quite the opposite of what was stated here...they still believe in the product, so much so they stated they would entertain making a move to continue to represent it. Pretty strong statement if you ask me
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 3, 2016 14:39:30 GMT -5
You are correct, I did not pick-up on your point from the original post. I now get it, and agree with you. Just an fyi, the rep I know felt quite the opposite of what was stated here...they still believe in the product, so much so they stated they would entertain making a move to continue to represent it. Pretty strong statement if you ask me not sure if that would be a good idea unless the contract is re written with Mannkind having the power and huge upfront payment
|
|
|
Post by mnholdem on Feb 3, 2016 14:46:48 GMT -5
Sanofi marketing of Afrezza is a joke and in my opinion harmful given the crappy creative that they are utilizing. Last night I watched an interview with former Apple CEO John Sculley about the first Superbowl ad for the McIntosh computer. The commercial was called "1984" and the Apple Board of Directors said that it was the stupidest commercial that they had ever seen and forbade it to be aired. Steve Jobs, John Sculley and another individual (I forget his name) did not have time for another, so they ran the commercial.
It still ranks as the Top 5 SuperBowl commercial of all time and the advertisement is credited for starting a revolution in how products are advertised. finance.yahoo.com/news/apple-1984-super-bowl-ad-almost-never-happened-210150331.html
---
How does this apply to Afrezza? Simply that you've got a bunch of old French aristocrats sitting on their derrieres making decisions about an American product that could have tremendous appeal and revolutionize diabetes care. They are NOT visionary. If they or their new CEO were forward-thinkers, they would have easily made the world's first inhalable monomer human insulin into a mega-blockbuster.
Now that job will fall to others...
|
|
|
Post by BlueCat on Feb 3, 2016 19:03:02 GMT -5
Sanofi marketing of Afrezza is a joke and in my opinion harmful given the crappy creative that they are utilizing. Last night I watched an interview with former Apple CEO John Sculley about the first Superbowl ad for the McIntosh computer. The commercial was called "1984" and the Apple Board of Directors said that it was the stupidest commercial that they had ever seen and forbade it to be aired. Steve Jobs, John Sculley and another individual (I forget his name) did not have time for another, so they ran the commercial.
It still ranks as the Top 5 SuperBowl commercial of all time and the advertisement is credited for starting a revolution in how products are advertised. finance.yahoo.com/news/apple-1984-super-bowl-ad-almost-never-happened-210150331.html
---
How does this apply to Afrezza? Simply that you've got a bunch of old French aristocrats sitting on their derrieres making decisions about an American product that could have tremendous appeal and revolutionize diabetes care. They are NOT visionary. If they or their new CEO were forward-thinkers, they would have easily made the world's first inhalable monomer human insulin into a mega-blockbuster.
Now that job will fall to others...
And are you coming out of retirement to have conversations with them?
|
|